StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510 (k) clearance for Theracor, the first human umbilical cord-derived medical device to be offered in sheet form. This ...

StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human umbilical cord-derived medical device to be offered in sheet form. This ...

A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

After each blood exchange, there is a shift in my body, not dramatic, not instant, not loud. It is subtle. Quiet. Gentle. Almost like my body is exhaling, breathing out what it has carried and ...

Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, today ...

Baptist Health Wound & Hyperbaric Center–Fort Smith welcomes back APRN Jennifer Williams, expanding access to advanced wound ...

The 84-year-old decedent was admitted to the defendant facility from the hospital with one stage 1 pressure injury to her sacrum, incontinence and a Braden score of 13. She was totally dependent on ...

Freedom Bank Kazakhstan, a part of Freedom Holding Corp., a NASDAQ-listed finance and technology group, received the award in ...

Membrane and AlloPatch (R) Pliable are among the 18 tissues that will be covered under the newly updated Medicare Local Coverage Determinations (LCDs) for skin substitute grafts/cellular and ...

The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel” (UMIH), marking a breakthrough in the field of gastrointestinal medicine.

The publication presents interim results from two prospective, randomized, multicenter clinical studies evaluating AmchoPlast™, Cellution Biologics’ dehydrated human amnion-intermediate layer-chorion ...

(MENAFN- Newsfile Corp) Calgary, Alberta--(Newsfile Corp. - December 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce its ...